A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Early, presymptomatic intervention with oseltamivir (corresponding to the onset of a published host-based genomic signature of influenza infection) resulted in decreased overall influenza symptoms (aggregate symptom scores of 23.5 vs 46.3), more rapid resolution of clinical disease (20 hours earlier), reduced viral shedding (total median tissue culture infectious dose [TCID50] 7.4 vs 9.7), and significantly reduced expression of several inflammatory cytokines (interferon-γ, tumor necrosis factor-α, interleukin-6, and others). The host genomic response to influenza infection is robust and may provide the means for early detection, more timely therapeutic interventions, a meaningful reduction in clinical disease, and an effective molecular means to track response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panels containing a limited number of host biomarkers are being developed as diagnostic assays for influenza77, tuberculosis70 and bacterial sepsis78.”
From Clinical metagenomics (2019) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550 · cited 1×
“given oseltamivir at a defined timepoint 28 hours after inoculation [7] and confirms that earlier intervention shows promise for improved clinical outcomes in influenza infection.”
BackgroundKaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
Zaas, A. K., Chen, M., Varkey, J., Veldman, T., Hero, A. O., Lucas, J., Huang, Y., Turner, R., Gilbert, A., Lambkin-Williams, R., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.07.006 · Cited by 421 · cited 1×
“After 24 hours in quarantine, we instilled 10(6) of median tissue culture infectious dose (TCID50) influenza A into bilateral nares of subjects using standard methods [12].”
MethodSelf-citationWoods, C. W., McClain, M. T., Chen, M., Zaas, A. K., Nicholson, B. P., Varkey, J., Veldman, T., Kingsmore, S. F., Huang, Y., Lambkin-Williams, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052198 · Cited by 183 · cited 3×
“0 Arrays (Affymetrix, Santa Clara, CA) as previously described [11, 13] (see Supplementary Methods for full experimental details).”
BackgroundMethodSelf-citationFry, A. M., Goswami, D. R., Nahar, K., Sharmin, A. T., Rahman, M., Gubareva, L. V., Azim, T., Bresee, J., Luby, S. P., & Brooks, W. A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70267-6 · Cited by 157 · cited 1×
“however, little is known about how such treatment effects molecular markers of host recovery [9, 10].”
BackgroundA Host-Based RT-PCR Gene Expression Signature to Identify Acute Respiratory Viral Infection
Zaas, A. K., Burke, T., Chen, M., McClain, M., Nicholson, B., Veldman, T., Tsalik, E. L., Fowler, V., Rivers, E. P., Otero, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006280 · Cited by 139 · cited 7×
“We obtained nasal lavage samples from each subject daily for qualitative viral culture and and/or quantitative influenza reverse transcription-polymerase chain reaction (RT-PCR) to assess the success and timing of infection [14].”
BackgroundMethodSelf-citationGene-expression profiling of peripheral blood mononuclear cells in sepsis*
Tang, B. M. P., McLean, A. S., Dawes, I. W., Huang, S. J., & Lin, R. C. Y. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819b52fd · Cited by 137
Ng, S., Cowling, B. J., Fang, V. J., Chan, K. H., Ip, D., Cheng, C. K. Y., Uyeki, T. M., Houck, P. M., Peiris, M. J. S., & Leung, G. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650458 · Cited by 121 · cited 1×
“however, little is known about how such treatment effects molecular markers of host recovery [9, 10].”
BackgroundGene-expression profiling of peripheral blood mononuclear cells in sepsis
Tang, B. M. P., McLean, A. S., Huang, S., Dawes, I. W., & Lin, R. C. Y. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a9ef74 · Cited by 111
Cited by
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Dysregulated transcriptional responses to SARS-CoV-2 in the periphery
McClain, M. T., Constantine, F. J., Henao, R., Liu, Y., Tsalik, E. L., Burke, T. W., Steinbrink, J. M., Petzold, E., Nicholson, B. P., Rolfe, R. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21289-y · Cited by 128
Self-citationNew Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance
Tsalik, E. L., Bonomo, R. A., & Fowler, V. G. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-052716-030320 · Cited by 74
Self-citationLambkin‐Williams, R., Noulin, N., Mann, A., Catchpole, A. P., & Gilbert, A. S. (2018) · Respiratory Research · doi:10.1186/s12931-018-0784-1 · Cited by 58
“In recent years it has been used to demonstrate “gene switching signatures” that could form part of a diagnostic that would reveal infected individuals before they become symptomatic, in the early stages of infection; this could be vitally important in the event of a pandemic [176, 177].”
MethodSelf-citationMcClain, M. T., Constantine, F. J., Nicholson, B. P., Nichols, M., Burke, T. W., Henao, R., Jones, D. C., Hudson, L. L., Jaggers, L. B., Veldman, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30486-2 · Cited by 44
Self-citation
Metadata
- Authors
- McClain, M. T., Nicholson, B. P., Park, L. P., Liu, T.-Y., Hero, A. O., Tsalik, E. L., Zaas, A. K., Veldman, T., Hudson, L. L., Lambkin-Williams, R., Gilbert, A., Burke, T., Nichols, M., Ginsburg, G. S., & Woods, C. W.
- Affiliations
- Duke University (US)
- Veterans Health Administration (US)
- National Center for Genome Resources (US)
- University of Michigan (US)
- hVIVO, London, United Kingdom
- hVIVO (United Kingdom) (GB)
- Corresponding author
- McClain, Micah T.
- ORCID
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-01
- Volume
- 3
- Issue
- 1
- Pages
- ofw007-ofw007
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC4771939
- OpenAlex
- W2256139303
- Cited by
- 28
- References
- 15
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 2
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Veteran's Affairs Medical Center (1IK2CX000611)
- Defense Advanced Research Projects Agency (lN66001-07-C-0092)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- influenza, presymptomatic detection, oseltamivir, antiviral therapy, viral shedding, inflammatory cytokines, interferon-gamma, TNF-α, interleukin-6, host immune response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses. https://app.cochat.ai/papers/10.1093/ofid/ofw007
- The paper
- McClain, M. T., Nicholson, B. P., Park, L. P., Liu, T.-Y., Hero, A. O., Tsalik, E. L., Zaas, A. K., Veldman, T., Hudson, L. L., Lambkin-Williams, R., Gilbert, A., Burke, T., Nichols, M., Ginsburg, G. S., & Woods, C. W. (2016). A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofw007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.